Phases I–III Clinical Trials Using Adult Stem Cells

Phases I–III Clinical Trials Using Adult Stem Cells

Bibliographic Details
Main Authors:	Jeffrey M. Gimble, Bruce A. Bunnell, Louis Casteilla, Jin Sup Jung, Kotaro Yoshimura
Format:	Article
Language:	English
Published:	Hindawi Limited 2010-01-01
Series:	Stem Cells International
Online Access:	http://dx.doi.org/10.4061/2010/604713

Similar Items

Analysis of the Pro- and Anti-Inflammatory Cytokines Secreted by Adult Stem Cells during Differentiation
by: Amy L. Strong, et al.
Published: (2015-01-01)

Phases I–III Clinical Trials Using Adult Stem Cells
by: Ricardo Sanz-Ruiz, et al.
Published: (2010-01-01)

Competitive DNA transfection formulation via electroporation for human adipose stem cells and mesenchymal stem cells
by: Flanagan Michael, et al.
Published: (2012-04-01)

Culture and Use of Mesenchymal Stromal Cells in Phase I and II Clinical Trials
by: Bourin Philippe, et al.
Published: (2010-01-01)

Where is clinical research for radiotherapy going? Cross-sectional comparison of past and contemporary phase III clinical trials
by: Sunmin Park, et al.
Published: (2020-02-01)

Phase III clinical trials: No ethics no paradigm
by: Jhony A. De La Cruz-Vargas
Published: (2021-03-01)

Comparison of human adult stem cells from adipose tissue and bone marrow in the treatment of experimental autoimmune encephalomyelitis
by: Semon, Julie, et al.
Published: (2014)

Phases 1–3 Clinical Trials Using Adult Stem Cells in Osteonecrosis and Nonunion Fractures
by: Jean-Philippe Hauzeur, et al.
Published: (2010-01-01)

PPARs, RXRs, and Stem Cells
by: Jeffrey M. Gimble, et al.
Published: (2007-01-01)

Evaluation and recommendations on good clinical laboratory practice guidelines for phase I-III clinical trials.
by: Marcella Sarzotti-Kelsoe, et al.
Published: (2009-05-01)

Obesity Enhances the Conversion of Adipose-Derived Stromal/Stem Cells into Carcinoma-Associated Fibroblast Leading to Cancer Cell Proliferation and Progression to an Invasive Phenotype
by: Amy L. Strong, et al.
Published: (2017-01-01)

The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov
by: Y Que, et al.
Published: (2018-12-01)

Hepatic profile analyses of tipranavir in Phase II and III clinical trials
by: Rockstroh Jürgen, et al.
Published: (2009-12-01)

Clinical trial of fibrinselective thrombolytic pharmaceutical agent «FORTELYZIN®» (III Phase)
by: S S Markin, et al.
Published: (2012-03-01)

An Alternative Phase II/III Design in Clinical Trials for Continuous Endpoint
by: Liu, Chia-Pei, et al.
Published: (2010)

Phase I/II Clinical Trials Using Gene-Modified Adult Hematopoietic Stem Cells for HIV: Lessons Learnt
by: Ronald T. Mitsuyasu, et al.
Published: (2011-01-01)

An Adaptive Seamless Phase II/III Design for Binary Endpoints in Clinical Trials
by: Yuan, Ming-Jun, et al.
Published: (2012)

Machine Learning Predicts Outcomes of Phase III Clinical Trials for Prostate Cancer
by: Felix D. Beacher, et al.
Published: (2021-05-01)

Imposing Phase II and Phase III Clinical Trials of Targeted Drugs for Glioblastoma: Current Status and Progress
by: Yaning Wang, et al.
Published: (2021-09-01)

Transplantation of autologous adipose stem cells lacks therapeutic efficacy in the experimental autoimmune encephalomyelitis model.
by: Xiujuan Zhang, et al.
Published: (2014-01-01)

An Innovative, Comprehensive Mapping and Multiscale Analysis of Registered Trials for Stem Cell‐Based Regenerative Medicine
by: Paul Monsarrat, et al.
Published: (2016-06-01)

Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial
by: Lin Kong, et al.
Published: (2019-02-01)

The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies
by: Andres Garcia-Sampedro, et al.
Published: (2021-02-01)

Predicting enrollment performance of investigational centers in phase III multi-center clinical trials
by: Rutger M. van den Bor, et al.
Published: (2017-09-01)

Dose selection in seamless phase II/III clinical trials based on efficacy and toxicity
by: Kimani, Peter Kung'u
Published: (2009)

Dose Escalation of Lobaplatin Concurrent with IMRT for the Treatment of Stage III-IVb NPC: A Phase I Clinical Trial
by: Si-Yang Wang, et al.
Published: (2018-08-01)

Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials
by: Linda Spiegelberg, et al.
Published: (2019-02-01)

Early Clinical Trial Design Recommendations in Oncology Based on Overall Success across Phases I, II, and III
by: Stark, Amy S. Ruppert
Published: (2017)

Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.
by: Steffen Borrmann, et al.
Published: (2008-11-01)

A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials
by: Elisabete Cruz Da Silva, et al.
Published: (2021-04-01)

Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults.
by: Phirangkul Kerdpanich, et al.
Published: (2018-06-01)

Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer’s disease dementia: a phase I clinical trial
by: Hee Jin Kim, et al.
Published: (2021-09-01)

Efficacy of intravenous tigecycline in patients with Acinetobacter complex infections: results from 14 Phase III and Phase IV clinical trials
by: Tucker H, et al.
Published: (2017-11-01)

Statistical design of Phase II/III clinical trials for testing therapeutic interventions in COVID-19 patients
by: Shesh N. Rai, et al.
Published: (2020-08-01)

Endovascular equipoise shift in a phase III randomized clinical trial of sonothrombolysis for acute ischemic stroke
by: Andrei V. Alexandrov, et al.
Published: (2019-07-01)

An adaptive seamless phase II/III clinical trial design incorporating short-term endpoint information
by: Stallard Nigel
Published: (2011-12-01)

Decision Making in the PICU: An Examination of Factors Influencing Participation Decisions in Phase III Randomized Clinical Trials
by: Laura E. Slosky, et al.
Published: (2014-01-01)

Obtaining valid laboratory data in clinical trials conducted in resource diverse settings: lessons learned from a microbicide phase III clinical trial.
by: Tania Crucitti, et al.
Published: (2010-10-01)

P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials
by: Stevens G, et al.
Published: (2009-10-01)

Safety and effectiveness of stem cell therapies in early-phase clinical trials in stroke: a systematic review and meta-analysis
by: Anjali Nagpal, et al.
Published: (2017-08-01)